Silencing cathepsin B and uPAR can inhibit the c-Met pathway and upregulate H2AX, increasing the radiotherapy sensitivity of glioma cells (138), and the knockdown of cathepsin L has a similar effect (139). The gene discussed is CTSL; the disease is central nervous system cancer.